Impact of a sirolimus/tacrolimus-based immunosuppressive regimen on kidney function after islet transplantation

Transplantation Proceedings

Volumn 37, Issue 2, 2005, Pages 1326-1327

  Andres, A ^a   Toso, C ^a   Morel, P ^a   Demuylder Mischler, S ^a   Bosco, D ^a   Baertschiger, R ^a   Pernin, N ^a   Bucher, P ^a   Majno, P E ^a   Buhler L H ^a   Berney, T ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; RAPAMYCIN; TACROLIMUS;

ADULT; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; CREATININE BLOOD LEVEL; FOLLOW UP; GRAFT PATENCY; GRAFT REJECTION; HUMAN; KIDNEY FUNCTION; METABOLIC BALANCE; PANCREAS ISLET TRANSPLANTATION; PRIORITY JOURNAL; PROTEINURIA;

EID: 17844381607     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2004.12.040     Document Type: Conference Paper

References (5)

1. Official website of the International Islet Transplant Registry (ITR): Available at: www.med.uni-giessen.de/itr/. Accessed August 31, 2004
2. E.A. Ryan, J.R. Lakey, B.W. Paty Successful islet transplantation: continued insulin reserve provides long-term glycemic control Diabetes 51 2002 2148
3. T. Berney, L.H. Buhler, P. Majno Immunosuppression for pancreatic islet transplantation Transplant Proc 36 2004 362S
4. V.C. McAlister, Z. Gao, K. Peltekian Sirolimus-tacrolimus combination immunosuppression Lancet 355 2000 376
5. B. Hirshberg, K.I. Rother, B.J. Digon 3rd Benefits and risks of solitary islet transplantation for type 1 diabetes using steroid-sparing immunosuppression: response to Charles and Selam Diabetes Care 27 2004 1250